Related Experiment Video
Updated: Jul 20, 2025
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.8K
[Myelodysplastic syndrome : prognostic factors]
Emmanuel Gyan1, Sylvain Thépot2
1CHRU de Tours, service d'hématologie, Bretonneau, Tours, France.
Bulletin Du Cancer
|August 3, 2023
Summary
The prognostic evaluation of myelodysplastic syndromes (MDS) has improved with new scores. The IPSS-M score, incorporating molecular mutations, is set to become the new standard for predicting MDS outcomes.
Area of Science:
- Hematology
- Oncology
- Medical Diagnostics
Context:
- Myelodysplastic syndromes (MDS) prognostication has evolved significantly.
- Traditional prognostic scores relied on cytopenias, blast counts, and cytogenetics.
- Recent advancements include the integration of molecular mutation data.
Purpose:
- To outline the evolution of prognostic scoring in myelodysplastic syndromes.
- To highlight the key variables incorporated into modern prognostic models.
- To introduce the IPSS-M score as a forthcoming reference standard.
Summary:
- Prognostic evaluation for MDS has advanced due to evolving classifications and outcome prediction improvements.
- Numerous prognostic scores consider blood cytopenias, bone marrow blasts, cytogenetics, and molecular mutations.
- The International Prognostic Scoring System for Myelodysplastic Syndromes-Molecular (IPSS-M) score, established in 2022, integrates these variables.
Impact:
- The IPSS-M score is expected to become the primary reference for MDS prognostic evaluation.
- Availability of molecular information is crucial for the widespread adoption of the IPSS-M score.
- Improved prognostic accuracy will aid in personalized treatment strategies for MDS patients.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K